Literature DB >> 16107170

[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].

Alfonso Javier Carrillo-Muñoz1, Carmen Delia Cárdenes, Bartolomé Carrillo-Orive, Virginia Rodríguez, Osacr Del Valle, José Bou Casals, Pilar Ariadna Ezkurra, Guillermo Quindós.   

Abstract

We have studied the in vitro antifungal activity of voriconazole, fluconazole and itraconazole against 252 clinical isolates of dermatophytes and Scopulariopsis brevicaulis by a standardized agar diffusion method (NeoSensitabs). Several important factors such as temperature (28 degrees C vs. 35 degrees C) and incubation time (2-10 days vs. 18-74 h) were adapted to dermatophytes and Scopulariopsis requirements. Voriconazole showed an excellent activity against most species of dermatophytes, higher than itraconazole and fluconazole. However, S. brevicaulis isolates were highly resistant to all azoles used in this study. Voriconazole might be an interesting antifungal alternative to refractory superficial mycoses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107170     DOI: 10.1016/s1130-1406(05)70019-x

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  6 in total

1.  In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller-Hinton Agar Plates.

Authors:  Jari Intra; Cecilia Sarto; Selene Mazzola; Chiara Fania; Natalia Tiberti; Paolo Brambilla
Journal:  Mycopathologia       Date:  2019-07-11       Impact factor: 2.574

3.  Investigation of In Vitro Activity of Five Antifungal Drugs against Dermatophytes Species Isolated from Clinical Samples Using the E-Test Method.

Authors:  Ayse Esin Aktas; Nimet Yigit; Akin Aktas; Sultan Gamze Gozubuyuk
Journal:  Eurasian J Med       Date:  2014-02

4.  In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.

Authors:  Limin Yao; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

5.  Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for In Vitro Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole against Madurella mycetomatis.

Authors:  Bertrand Nyuykonge; Lukas van Amelsvoort; Kimberly Eadie; Ahmed H Fahal; Annelies Verbon; Wendy van de Sande
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

6.  21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses.

Authors:  Anna B Macura; Magdalena Skóra
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.